Transferrin as a targeting ligand for liposomes and anticancer drugs

Current Pharmaceutical Design

Volumn 5, Issue 6, 1999, Pages 443-451

  Singh, M ^a  

^a FLORIDA A AND M UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; ANTINEOPLASTIC AGENT; APOTRANSFERRIN; AVIDIN; CARBOPLATIN; CISPLATIN; CYTOLYSIN; DAUNORUBICIN; DIHYDROFOLATE REDUCTASE INHIBITOR; DOXORUBICIN; EQUINATOXIN; GLUTARALDEHYDE; IMMUNOTOXIN; INTERLEUKIN 2; LIPOSOME; METHOTREXATE; MICROSPHERE; MONENSIN; PACLITAXEL; POLYLYSINE; POLYMER; PROTAMINE; RICIN A; SCHIFF BASE; TRANSFERRIN; TRANSFERRIN RECEPTOR; UNINDEXED DRUG; VERAPAMIL; VINCRISTINE; ZINOSTATIN;

ANIMAL CELL; CANCER CELL CULTURE; DISULFIDE BOND; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG RESEARCH; GENE TARGETING; HUMAN; HUMAN CELL; KAPOSI SARCOMA; MESOTHELIOMA; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; ANTINEOPLASTIC AGENTS; DRUG CARRIERS; GENE THERAPY; HUMANS; LIPOSOMES; METHOTREXATE; TRANSFERRIN;

EID: 0032985063     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (51)

1. Robbins, E.; Pederson, T. Proc. Natl. Acad. U.S.A 1991, 66, 1244.
2. Rudland P.S.; Durbin, H.; Clingan, D.; DeAusa, L.J. Biochem Biophys Res. Commun, 1991, 75, 556.
3. Kohgo, Y.; Nittsu, Y.; Nishisato, T.; Kato, J. Cell Biol. Int. Rep. 1987, 11, 871-879.
4. Kohgo, Y.; Niitsu, Y; Nishisato, T.; Urushizaki, Y.; Kondo, H.; Fukushima, M.; Tsushima, N. and Urushizaki, I. Trf receptors of tumor cells-potential tools for diagnosis and treatment of malignancies. In "Proteins of Iron Storage and Transport," ed. Spic, G.; Momtruil, J.; Chrichton, R.R. and Mazurier, J.; Elsevier/North-Holland Biomedical Press, Amsterdam. , 1985, pp. 155-169 (1985).
5. Hopkins, C.R. and Trowbridge, I.S. J. Cell Bio. 1983, 97, 508-521.
6. Sutherland, R.; Delia, D.; Schneider, C.; Newman, R.; Kemshead, J. and Greaves, M. Proc. Natl. Acad. Sci., 1981, 78, 4515-4519.
7. Cavanaugh, P.G.; and Nicolson, G.L. J. Cell. Biochem., 1991, 47, 261-271.
8. Denstman, S.; Hromchak, R.; Guan, X.P.; and Bloch, A. J. Biol. Chem. 1991, 266, 14873-14876.
9. Chakal Ross, M.; and Zetter, B.R. Proc. Natl. Acad. Sci. U.S.A. 1993, 89, 6197-6201.
10. Inoue, T.; Cavanaugh, P.G.; Steck, P.A.; Brummer, N.; and Nicolson, G.L. J. Cell. Physiol. 1993, 156, 212-217.
11. Barabas, K.; and Faulk, W.P. Biochem. Biophys. Res. Commun. 1993, 197, 702-708.
12. Singh, M.; Faulkner, D.; Chose, T.; Mezei, M. Cancer Immunol. Innumother., 1988, 27, 17-25.
13. Singh, M.; Chose, T.; Mezei, M.; and Belitsky, P. Cancer Lettl. 1991, 56, 97-102.
14. Kralovec, J.; Spencer, G.; Blair, A. H.; Singh, M.; Chose , T. J. Med. Chem. 1989, 32, 2426-2431
15. Ahmed, I.; Longnecker, M; Samuel, J.; Allen, T. M. Cancer Res., 1993, 53, 1484-1488.
16. Williams, S.; Alosco, T. R.; Mayhew, E., et al. Cancer Res. 1993, 53, 3964-3967.
17. Noda, H.; Ogasawara, T.; Iida, T., et al. Biol. Pharm. Bull. 1994, 17, 1246-1250.
18. Yang, H. M.; Reisfeld, R. A. Proc. Natl. Acad. Sci U.S.A. 1988, 85, 1189-1193.
19. Yu, D.; Chu, T. M.; Yeh, M., et al. Journal of Urology, 1988, 140, 415-421.
20. Trail, R. A.; Willner, D.; Lasch, S. J.; Henderson, A. J.; Hellstrom, R. A.; et al. Science 1993, 261, 212-215.
21. Kedar, E.; Rutkowski, Y.; Braun, N.; Emanuel, N.; Barenholz, Y. J. Immunother. 1994, 16, 47-59.
22. Narayani, R.; Panduranga Rao, K. Intern. J. Pharm. 1996, 142, 25-32.
23. Goundalkar, A.; Ghose T.; Mezei, M. J. Pharm Pharmacol 1984, 36, 465-466.
24. Singh, M.; Griffin, T; Salimi, A.; Micetich, R. Cancer Lett. 1994, 84, 15-21.
25. Carlsson, J.; Drevin, H.; Axen R. I. Biochem J. 1978, 173, 723-737.
26. Stavridis, J. C.; Deliconstantinos, G; Psallidpopulos, M. C.; Armenakas, N. A.; Hadjiminas, D. J. and Hadjiminas, J. Exp Cell Res. 1986, 164, 558-572.
27. Sizensky, J. A.; Barabas, K.; Faulk, W. P.; Am.. J. Reprod. Immunol. 1992, 27, 163-166.
28. Yeh, C. G.; and Faulk, W. P.; Clin. Immunol. Immunopathol. 1984 32, 1-11.
29. Barabas, K.; Sizensky, J. A.; and Faulk, W. P. J. Biol. Chem. 1992, 267, 9437-9442.
30. Berczi, A.; Sizensky, J. A.; Crane, F. L.; and Faulk, W. P. Biochim. Biophys. Acta. 1991, 1073, 562-570.
31. Lemieux P.; Page, M. Anticancer Res. 1994, 14, 397-403.
32. Fritzer, M.; Barabas, K.; Szuts, V.; Berczi, A.; and others. Int. J. Cancer. 1992, 52, 619-623.
33. Griffin, T. W.; Richardson, C.; LePage, D.; et al Cancer Res. 1993, 47, 4266-4282.
34. Griffin, T.; Raso, V. Cancer Res. 1993, 51, 4316-4322.
35. Raso, V.; McGrath, J. J. Natl Cancer Inst. 1993, 81, 622-627.
36. Sun, I. L.; Sun, E. E.; Crane, F. L.; Morre, D. J.; Faulk, W. P. J. Natl Cancer Inst. 1992, 81, 622-627.
37. Fritzer, M.; Szerkeres, T.; Szus, V.; Jarayan, H.; Goldenberg, H., Biochemical Pharmacology 1996, 51, 489-493.
38. Ruthner, M.; Berczi, A.; and Goldenberg, H. Life Sci. 1994, 54, 35-40.
39. Hatano, T.; Ohkawa, K.; Matsuda, M. Tumor Biol. 1993, 14, 288-294.
40. Kohgo, Y.; Kondo, H.; Kato, J.; Saski, K.; Tsushima, N.; Nishisato, T.; Hirayama; M., Fujikawa; K., Shintani; N., Mogi Y. and Niitsu, Y. J. Cancer Res. 1990 ,81, 91-99.
41. Martell, L.A.; Agarwal, A.; Ross, D.A.; Muraszko, K.M. Cancer Res. 1993, 53, 1348-1353.
42. Faulk, W.P.; Taylor C.C.; Yeh, C.J.G and McIntyre, J. A Mol Biother. 1990, 2, 57-60.
43. Berczi, A.; Rithner M; Szuts V.; Fritzer, M. Eur. J. Biochem. 1993, 213, 427-436.
44. Singh, M.; Atwal H.; Micetic,h R. Anticancer Res . 1998, 18, 1423-1428.
45. Ruthner, M.; Berczi, A.; and Goldenberg, H. Life Sci. 1994, 54, 35-40.
46. Cotton, M.; Langle-Rouault, F.; Kirlappos, H. Proc. Natl. Acad. Sci. USA 1990, 87, 4033-4037.
47. Zatloukal, K.; Schmidt, W.; Cotton, M. Gene 1993, 135, 199-207.
48. Joubert, R. D.; Ariatti, M. J. Drug Target 1995, 2, 509-515.
49. Chen, J.; Garmous, S.; Takayanagi, F. FEBS Lett. 1994, 338, 167-169.
50. Pederzolli, C.; Belmonte, G.; Serra, M. D.; Macek, P. Bioconjugate Chem. 1995 6, 166-173.
51. Raso, V.; Basala, M.; J. Biological Chem. 1984, 259(2), 1143-1149.